Q-omics provides the consensus-scored B4GALNT2P1 profile across patient tissues and cancer cell-line models. B4GALNT2P1 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, B4GALNT2P1 RNA expression shows 6,317 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight SKCM, and COAD as cancer lineages where B4GALNT2P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.